Clément Bertholet is Partner at AdBio Partners, and spent the first part of this carreer between life science and corporate finance. He graduated from Ecole Normale Supérieure (ENS Paris Saclay) with a major in Biology and Health and several experiences in Institut Curie and Cancer Research UK, before joining the Corps des Mines, a senior officials corpse, of which he is engineer in chief.

Before being promoted Partner, Clément was Operating partner for AdBio, co-founder and CEO of Calida Therapeutics (thrombo-inflammation), and former VP Corp. Dev. of Thabor Therapeutics (mucosal inflammation).

Before joining AdBio Partners, Clément was deputy governmental delegate for business restructuring, reporting directly to the Ministers in charge of Economy and Finance, Industry, and Labor, and head of a business restructuring unit. He created and managed a €500m credit line to support companies affected by Covid-19 economic crisis. Prior to this, Clément held several positions at the French Treasury, BNP Paribas CIB New York and GDF Suez.